PULLMAN, Wash. — A group of researchers at Washington State University has found evidence that the urocortin 3 (UCN3) gene may provide pharmaceutical companies with a new target for development of drugs to address obesity and its related conditions, such as type 2 diabetes. In a paper published Wednesday in the inaugural issue of PLoS […]